Not FDA-approved
Immune & defense
KPV
Evidence
Lab and animal studies
Class
Tripeptide from alpha-MSH
KEY TAKEAWAY
KPV is a three-amino-acid fragment of alpha-MSH. In lab and animal models it calms inflammation in the gut and skin. It has not been tested in large human trials.
Written by the Veylo editorial team · Updated
November 2026
What it is
A short peptide from the tail of alpha-MSH
Studied for
Inflammatory bowel disease and skin inflammation
Key fact
Reduced inflammation in animal colitis models; no large human trials
Route
Oral or topical (research use)
Evidence strength
Lab and animal studies
KPV is made of the amino acids lysine, proline and valine, the last three residues of alpha-MSH.
Lab studies suggest it reduces inflammatory signaling inside cells, including the NF-kB pathway.
KPV is not approved by the FDA for any condition.
Studied in animals for colitis and inflammatory skin conditions. It has no approved medical use.
Human safety data are lacking, so risks are not well defined.
Primary literature for this entry is being compiled.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.